Harmony Biosciences Announces 2022 Funding Recipients of Patients at the Heart And Progress at the Heart Award Programs

Harmony Biosciences Holdings Inc revealed the funding recipients of its Patients at the Heart and Progress at the Heart award programs. The Patients at the Heart program, which launched in 2019, underscores Harmony’s commitment to support the needs of people affected by rare neurological diseases. Over the last four years, the program has awarded numerous … Read more